Yu Meng
-
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 4
- Nephrology top 10%
- Acute Kidney Injury Research 4
- Genetics top 10%
- Mesenchymal stem cell research 6
-
- Extracellular vesicles in disease 11
- Circular RNAs in diseases 6
- RNA modifications and cancer 3
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Lilach O. LermanAlfonso EirinAndré J. van WijnenAmir LermanHui TangXiangyang ZhuPritha ChananaNa Zhao
- Cited by
- Cancer ResearchNephrologyGenetics
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yu Meng
43 papers receiving 562 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 143
- Nephrology 63
- Genetics 88
- Molecular Biology 327
- Physiology 65
Countries citing papers authored by Yu Meng
This map shows the geographic impact of Yu Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Meng more than expected).
Fields of papers citing papers by Yu Meng
This network shows the impact of papers produced by Yu Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Meng. The network helps show where Yu Meng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 8 | |
| 14 | 2021 | 9 | |
| 15 | 2021 | 3 | |
| 16 | 2020 | 3 | |
| 17 | 2020 | 25 | |
| 18 | 2019 | 1 | |
| 19 | 2014 | 8 | |
| 20 | 2014 | 19 |
About Yu Meng
Yu Meng is a scholar working on Nephrology, Cancer Research and Genetics, having authored 47 papers that have together received 568 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Extracellular vesicles in disease (11 papers), Mesenchymal stem cell research (6 papers), Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (4 papers), Acute Kidney Injury Research (4 papers), RNA modifications and cancer (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Cancer Research (143 citations), Nephrology (63 citations) and Genetics (88 citations). Yu Meng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lilach O. Lerman, Alfonso Eirin, André J. van Wijnen, Amir Lerman, Hui Tang, Xiangyang Zhu, Pritha Chanana, Na Zhao, Yi‐Fang Lin and Ying Zhu. Their work appears in journals such as Circulation, Scientific Reports and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.